CN103006359A - 仿生三维立体组织工程支架及其制备方法 - Google Patents
仿生三维立体组织工程支架及其制备方法 Download PDFInfo
- Publication number
- CN103006359A CN103006359A CN2012105660899A CN201210566089A CN103006359A CN 103006359 A CN103006359 A CN 103006359A CN 2012105660899 A CN2012105660899 A CN 2012105660899A CN 201210566089 A CN201210566089 A CN 201210566089A CN 103006359 A CN103006359 A CN 103006359A
- Authority
- CN
- China
- Prior art keywords
- growth factor
- basic knowledge
- analytical reagents
- bionic
- macromolecular fibre
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011664 nicotinic acid Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims description 28
- 239000000835 fiber Substances 0.000 claims abstract description 90
- 239000003102 growth factor Substances 0.000 claims abstract description 59
- 239000012528 membrane Substances 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 32
- 230000008569 process Effects 0.000 claims abstract description 18
- 239000002131 composite material Substances 0.000 claims abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 60
- 210000001519 tissue Anatomy 0.000 claims description 46
- 239000000243 solution Substances 0.000 claims description 42
- 238000009987 spinning Methods 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 238000001523 electrospinning Methods 0.000 claims description 37
- 108010010803 Gelatin Proteins 0.000 claims description 25
- 239000008273 gelatin Substances 0.000 claims description 25
- 229920000159 gelatin Polymers 0.000 claims description 25
- 235000019322 gelatine Nutrition 0.000 claims description 25
- 235000011852 gelatine desserts Nutrition 0.000 claims description 25
- 238000010041 electrostatic spinning Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 21
- 210000004623 platelet-rich plasma Anatomy 0.000 claims description 21
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 19
- 229920002521 macromolecule Polymers 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000011259 mixed solution Substances 0.000 claims description 18
- 229920001610 polycaprolactone Polymers 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 17
- 102000013275 Somatomedins Human genes 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 239000003431 cross linking reagent Substances 0.000 claims description 14
- 150000001718 carbodiimides Chemical class 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 238000011010 flushing procedure Methods 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 10
- 239000012046 mixed solvent Substances 0.000 claims description 10
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 8
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 239000002121 nanofiber Substances 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 7
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 7
- 238000004132 cross linking Methods 0.000 claims description 7
- 239000004632 polycaprolactone Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 6
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 6
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Substances ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- 239000004626 polylactic acid Substances 0.000 claims description 5
- VNTJGCYVIRTGMZ-PXGLAOGESA-N 2-[[2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-[[(2s)-2-[[2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-oxopentanoyl]amino]acety Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC(C)C)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)NCC(O)=O)C1=CC=C(O)C=C1 VNTJGCYVIRTGMZ-PXGLAOGESA-N 0.000 claims description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 4
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 4
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 4
- 102400001368 Epidermal growth factor Human genes 0.000 claims description 4
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 4
- 108010022355 Fibroins Proteins 0.000 claims description 4
- 102100037362 Fibronectin Human genes 0.000 claims description 4
- 108010067306 Fibronectins Proteins 0.000 claims description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 4
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims description 4
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims description 4
- 101800003595 Osteogenic growth peptide Proteins 0.000 claims description 4
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims description 4
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 4
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 4
- 102100038081 Signal transducer CD24 Human genes 0.000 claims description 4
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 4
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 4
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 4
- 229940112869 bone morphogenetic protein Drugs 0.000 claims description 4
- 239000005482 chemotactic factor Substances 0.000 claims description 4
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 4
- 229940116977 epidermal growth factor Drugs 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 229920000669 heparin Polymers 0.000 claims description 4
- 229960002897 heparin Drugs 0.000 claims description 4
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical group C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 4
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 3
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims description 3
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 1
- FEPMHVLSLDOMQC-UHFFFAOYSA-N virginiamycin-S1 Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 claims 1
- 239000000839 emulsion Substances 0.000 abstract description 22
- 239000003814 drug Substances 0.000 abstract description 21
- 210000004027 cell Anatomy 0.000 abstract description 7
- 239000011258 core-shell material Substances 0.000 abstract description 7
- 230000001172 regenerating effect Effects 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 2
- 230000000717 retained effect Effects 0.000 abstract description 2
- 210000000130 stem cell Anatomy 0.000 abstract description 2
- 230000005611 electricity Effects 0.000 abstract 4
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000007547 defect Effects 0.000 description 16
- 239000000463 material Substances 0.000 description 16
- 230000000975 bioactive effect Effects 0.000 description 15
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 230000008439 repair process Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 230000008929 regeneration Effects 0.000 description 9
- 238000011069 regeneration method Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 229920002307 Dextran Polymers 0.000 description 6
- 238000013019 agitation Methods 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 6
- 210000000845 cartilage Anatomy 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000003223 protective agent Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000017423 tissue regeneration Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 238000011587 new zealand white rabbit Methods 0.000 description 5
- 230000002980 postoperative effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000011532 immunohistochemical staining Methods 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 229940126864 fibroblast growth factor Drugs 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 208000028990 Skin injury Diseases 0.000 description 2
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000009063 long-term regulation Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000010603 microCT Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000025366 tissue development Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 208000001738 Nervous System Trauma Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000010231 histologic analysis Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 208000028412 nervous system injury Diseases 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105660899A CN103006359A (zh) | 2012-12-24 | 2012-12-24 | 仿生三维立体组织工程支架及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105660899A CN103006359A (zh) | 2012-12-24 | 2012-12-24 | 仿生三维立体组织工程支架及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103006359A true CN103006359A (zh) | 2013-04-03 |
Family
ID=47955833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012105660899A Pending CN103006359A (zh) | 2012-12-24 | 2012-12-24 | 仿生三维立体组织工程支架及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103006359A (zh) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103205863A (zh) * | 2013-04-17 | 2013-07-17 | 钟春燕 | 一种细菌纤维素缓释敷料的制备方法 |
CN104027848A (zh) * | 2014-06-24 | 2014-09-10 | 中国人民解放军第四军医大学 | 一种用于牙周组织的生物支架材料及其制备方法 |
CN104998302A (zh) * | 2015-08-31 | 2015-10-28 | 中原工学院 | 一种以取向纳米纤维毡为骨架的纳米软骨修复材料及其制备方法 |
CN105013012A (zh) * | 2014-04-28 | 2015-11-04 | 韩国原子力医学院 | 提高吸水性的天然高分子纳米纤维复合材料制造方法 |
CN106049026A (zh) * | 2016-07-14 | 2016-10-26 | 四川大学 | 一种负载姜黄素的胶原‑pcl‑pvp复合微纳纤维膜及其制备方法 |
CN106110405A (zh) * | 2016-06-23 | 2016-11-16 | 国家纳米科学中心 | 一种功能化引导肌组织再生膜及其制备方法和应用 |
CN106334210A (zh) * | 2016-09-26 | 2017-01-18 | 沈阳尚贤微创医疗器械股份有限公司 | 一种多功能胶原蛋白纳米纤维修复膜及其制备方法 |
CN106635769A (zh) * | 2016-11-07 | 2017-05-10 | 深圳市达科为生物工程有限公司 | 细胞分离装置以及细胞分离方法 |
CN106730038A (zh) * | 2017-01-12 | 2017-05-31 | 广东泰宝医疗器械技术研究院有限公司 | 一种用于气管软组织修复的纤维膜及其制备方法 |
CN107213529A (zh) * | 2017-05-09 | 2017-09-29 | 苏州大学附属第二医院 | 一种用于提高成骨细胞粘附和成骨性能的可降解医用高分子三维材料的制备方法 |
CN107320787A (zh) * | 2017-07-20 | 2017-11-07 | 南开大学 | 一种牙周修复用多孔纤维膜材料及其制备方法 |
CN107530473A (zh) * | 2015-05-11 | 2018-01-02 | 阿莫生命科学有限公司 | 利用水溶性高分子的细胞培养支架 |
CN107970492A (zh) * | 2017-12-28 | 2018-05-01 | 广东泰宝医疗器械技术研究院有限公司 | 一种新型骨诱导再生医用膜及其制备方法 |
CN108245493A (zh) * | 2018-01-24 | 2018-07-06 | 上海市第十人民医院 | 一种基于可降解支架材料的减肥胶囊 |
CN108866820A (zh) * | 2017-05-12 | 2018-11-23 | 深圳瑞祥居科技发展有限公司 | 一种静电纺丝纳米纤维的制备方法及应用 |
CN109847105A (zh) * | 2019-01-10 | 2019-06-07 | 东华大学 | 一种新型神经导管支架及其制备方法和应用 |
CN109985279A (zh) * | 2019-04-01 | 2019-07-09 | 上海师范大学 | 一种复合有载药mof的微图案化纳米纤维材料及其制备方法和应用 |
CN110141687A (zh) * | 2019-05-30 | 2019-08-20 | 四川大学 | 一种引导牙周硬软组织再生梯度材料及其制备方法 |
CN110384823A (zh) * | 2019-07-19 | 2019-10-29 | 大连医科大学 | 基于丝素蛋白支架的仿生肝小叶及构建方法 |
CN110592686A (zh) * | 2019-08-30 | 2019-12-20 | 河南亚都实业有限公司 | 一种负载生长因子的微纳米复合膜 |
CN111067662A (zh) * | 2019-11-05 | 2020-04-28 | 南京艾澜德生物科技有限公司 | 重组胶原蛋白及其双层人造血管支架 |
CN111643731A (zh) * | 2019-03-04 | 2020-09-11 | 南开大学 | 全氟十四酸修饰的多孔支架材料及其制备方法 |
CN111705377A (zh) * | 2020-06-17 | 2020-09-25 | 北京天助畅运医疗技术股份有限公司 | 一种微孔型核壳结构可降解纳米纤维的制备方法 |
CN112210891A (zh) * | 2020-09-30 | 2021-01-12 | 上海交通大学医学院附属上海儿童医学中心 | 一种载Axitinib的纳米纤维膜及其制备方法和在外科术后防粘连中的应用 |
CN113398336A (zh) * | 2021-05-20 | 2021-09-17 | 四川大学华西第四医院 | 一种用于膀胱修复的复合支架材料及其制备方法 |
CN113648013A (zh) * | 2021-08-25 | 2021-11-16 | 心凯诺医疗科技(上海)有限公司 | 一种血流导向密网支架 |
CN114058663A (zh) * | 2021-11-10 | 2022-02-18 | 山东大学 | 一种多功能牡蛎活性多肽及其制备方法和应用 |
CN114150441A (zh) * | 2021-11-30 | 2022-03-08 | 中国人民解放军国防科技大学 | 一种光敏感的可介导神经化的骨修复支架材料及其制备方法 |
WO2022241852A1 (zh) * | 2021-05-19 | 2022-11-24 | 南方医科大学珠江医院 | 生物活性物质覆层聚酯网状片层支架的制备方法 |
CN115581805A (zh) * | 2022-10-13 | 2023-01-10 | 苏州大学附属第一医院 | 一种促进骨再生的水坝样双相仿生骨膜的制备方法 |
CN115996690A (zh) * | 2020-05-01 | 2023-04-21 | Askel医疗保健有限公司 | 用于制备用于医疗用途的三维支架的方法 |
CN116115825A (zh) * | 2021-11-15 | 2023-05-16 | 北京化工大学 | 一种眼结膜支架的制备方法、眼结膜支架及应用 |
CN118161669A (zh) * | 2024-05-14 | 2024-06-11 | 上海交通大学医学院附属第九人民医院 | 一种编织的生物牙根及其构建方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117755A (zh) * | 2007-06-25 | 2008-02-06 | 国家纳米科学中心 | 一种聚碳酸酯无纺布薄膜及其制备方法 |
CN102552976A (zh) * | 2012-02-20 | 2012-07-11 | 汪泱 | 物理包埋活性物质的组织工程支架材料及其制备方法 |
CN102580160A (zh) * | 2012-02-20 | 2012-07-18 | 汪泱 | 化学键接活性物质的组织工程支架材料及其制备方法 |
CN102813562A (zh) * | 2011-06-10 | 2012-12-12 | 冯淑芹 | 三维大孔径纳米级纤维支架与制备方法 |
-
2012
- 2012-12-24 CN CN2012105660899A patent/CN103006359A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117755A (zh) * | 2007-06-25 | 2008-02-06 | 国家纳米科学中心 | 一种聚碳酸酯无纺布薄膜及其制备方法 |
CN102813562A (zh) * | 2011-06-10 | 2012-12-12 | 冯淑芹 | 三维大孔径纳米级纤维支架与制备方法 |
CN102552976A (zh) * | 2012-02-20 | 2012-07-11 | 汪泱 | 物理包埋活性物质的组织工程支架材料及其制备方法 |
CN102580160A (zh) * | 2012-02-20 | 2012-07-18 | 汪泱 | 化学键接活性物质的组织工程支架材料及其制备方法 |
Non-Patent Citations (1)
Title |
---|
李珍等: "静电纺丝可纺性影响因素的研究成果", 《合成纤维》, no. 09, 30 September 2008 (2008-09-30), pages 6 - 9 * |
Cited By (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103205863B (zh) * | 2013-04-17 | 2016-02-10 | 钟春燕 | 一种细菌纤维素缓释敷料的制备方法 |
CN103205863A (zh) * | 2013-04-17 | 2013-07-17 | 钟春燕 | 一种细菌纤维素缓释敷料的制备方法 |
CN105013012A (zh) * | 2014-04-28 | 2015-11-04 | 韩国原子力医学院 | 提高吸水性的天然高分子纳米纤维复合材料制造方法 |
CN104027848A (zh) * | 2014-06-24 | 2014-09-10 | 中国人民解放军第四军医大学 | 一种用于牙周组织的生物支架材料及其制备方法 |
CN104027848B (zh) * | 2014-06-24 | 2015-10-14 | 中国人民解放军第四军医大学 | 一种用于牙周组织的生物支架材料及其制备方法 |
CN107530473A (zh) * | 2015-05-11 | 2018-01-02 | 阿莫生命科学有限公司 | 利用水溶性高分子的细胞培养支架 |
CN104998302A (zh) * | 2015-08-31 | 2015-10-28 | 中原工学院 | 一种以取向纳米纤维毡为骨架的纳米软骨修复材料及其制备方法 |
CN106110405A (zh) * | 2016-06-23 | 2016-11-16 | 国家纳米科学中心 | 一种功能化引导肌组织再生膜及其制备方法和应用 |
CN106049026B (zh) * | 2016-07-14 | 2017-12-19 | 四川大学 | 一种负载姜黄素的胶原‑pcl‑pvp复合微纳纤维膜及其制备方法 |
CN106049026A (zh) * | 2016-07-14 | 2016-10-26 | 四川大学 | 一种负载姜黄素的胶原‑pcl‑pvp复合微纳纤维膜及其制备方法 |
CN106334210A (zh) * | 2016-09-26 | 2017-01-18 | 沈阳尚贤微创医疗器械股份有限公司 | 一种多功能胶原蛋白纳米纤维修复膜及其制备方法 |
CN106635769A (zh) * | 2016-11-07 | 2017-05-10 | 深圳市达科为生物工程有限公司 | 细胞分离装置以及细胞分离方法 |
CN106635769B (zh) * | 2016-11-07 | 2019-06-28 | 深圳市达科为生物工程有限公司 | 细胞分离装置以及细胞分离方法 |
CN106730038A (zh) * | 2017-01-12 | 2017-05-31 | 广东泰宝医疗器械技术研究院有限公司 | 一种用于气管软组织修复的纤维膜及其制备方法 |
CN107213529A (zh) * | 2017-05-09 | 2017-09-29 | 苏州大学附属第二医院 | 一种用于提高成骨细胞粘附和成骨性能的可降解医用高分子三维材料的制备方法 |
CN107213529B (zh) * | 2017-05-09 | 2021-04-20 | 苏州大学附属第二医院 | 一种用于提高成骨细胞粘附和成骨性能的可降解医用高分子三维材料的制备方法 |
CN108866820A (zh) * | 2017-05-12 | 2018-11-23 | 深圳瑞祥居科技发展有限公司 | 一种静电纺丝纳米纤维的制备方法及应用 |
CN107320787A (zh) * | 2017-07-20 | 2017-11-07 | 南开大学 | 一种牙周修复用多孔纤维膜材料及其制备方法 |
CN107320787B (zh) * | 2017-07-20 | 2020-06-09 | 南开大学 | 一种牙周修复用多孔纤维膜材料及其制备方法 |
CN107970492A (zh) * | 2017-12-28 | 2018-05-01 | 广东泰宝医疗器械技术研究院有限公司 | 一种新型骨诱导再生医用膜及其制备方法 |
CN108245493A (zh) * | 2018-01-24 | 2018-07-06 | 上海市第十人民医院 | 一种基于可降解支架材料的减肥胶囊 |
CN109847105A (zh) * | 2019-01-10 | 2019-06-07 | 东华大学 | 一种新型神经导管支架及其制备方法和应用 |
CN111643731A (zh) * | 2019-03-04 | 2020-09-11 | 南开大学 | 全氟十四酸修饰的多孔支架材料及其制备方法 |
CN109985279A (zh) * | 2019-04-01 | 2019-07-09 | 上海师范大学 | 一种复合有载药mof的微图案化纳米纤维材料及其制备方法和应用 |
CN109985279B (zh) * | 2019-04-01 | 2021-11-19 | 上海师范大学 | 一种复合有载药mof的微图案化纳米纤维材料及其制备方法和应用 |
CN110141687B (zh) * | 2019-05-30 | 2021-10-08 | 四川大学 | 一种引导牙周硬软组织再生梯度材料及其制备方法 |
CN110141687A (zh) * | 2019-05-30 | 2019-08-20 | 四川大学 | 一种引导牙周硬软组织再生梯度材料及其制备方法 |
CN110384823B (zh) * | 2019-07-19 | 2021-08-03 | 大连医科大学 | 基于丝素蛋白支架的仿生肝小叶及构建方法 |
CN110384823A (zh) * | 2019-07-19 | 2019-10-29 | 大连医科大学 | 基于丝素蛋白支架的仿生肝小叶及构建方法 |
CN110592686B (zh) * | 2019-08-30 | 2020-06-26 | 河南亚都实业有限公司 | 一种负载生长因子的微纳米复合膜 |
CN110592686A (zh) * | 2019-08-30 | 2019-12-20 | 河南亚都实业有限公司 | 一种负载生长因子的微纳米复合膜 |
CN111067662A (zh) * | 2019-11-05 | 2020-04-28 | 南京艾澜德生物科技有限公司 | 重组胶原蛋白及其双层人造血管支架 |
CN115996690A (zh) * | 2020-05-01 | 2023-04-21 | Askel医疗保健有限公司 | 用于制备用于医疗用途的三维支架的方法 |
CN111705377A (zh) * | 2020-06-17 | 2020-09-25 | 北京天助畅运医疗技术股份有限公司 | 一种微孔型核壳结构可降解纳米纤维的制备方法 |
CN112210891A (zh) * | 2020-09-30 | 2021-01-12 | 上海交通大学医学院附属上海儿童医学中心 | 一种载Axitinib的纳米纤维膜及其制备方法和在外科术后防粘连中的应用 |
CN112210891B (zh) * | 2020-09-30 | 2023-06-16 | 上海交通大学医学院附属上海儿童医学中心 | 一种载Axitinib的纳米纤维膜及其制备方法和在外科术后防粘连中的应用 |
WO2022241852A1 (zh) * | 2021-05-19 | 2022-11-24 | 南方医科大学珠江医院 | 生物活性物质覆层聚酯网状片层支架的制备方法 |
CN113398336A (zh) * | 2021-05-20 | 2021-09-17 | 四川大学华西第四医院 | 一种用于膀胱修复的复合支架材料及其制备方法 |
CN113648013A (zh) * | 2021-08-25 | 2021-11-16 | 心凯诺医疗科技(上海)有限公司 | 一种血流导向密网支架 |
CN114058663A (zh) * | 2021-11-10 | 2022-02-18 | 山东大学 | 一种多功能牡蛎活性多肽及其制备方法和应用 |
CN116115825A (zh) * | 2021-11-15 | 2023-05-16 | 北京化工大学 | 一种眼结膜支架的制备方法、眼结膜支架及应用 |
CN114150441A (zh) * | 2021-11-30 | 2022-03-08 | 中国人民解放军国防科技大学 | 一种光敏感的可介导神经化的骨修复支架材料及其制备方法 |
CN115581805A (zh) * | 2022-10-13 | 2023-01-10 | 苏州大学附属第一医院 | 一种促进骨再生的水坝样双相仿生骨膜的制备方法 |
CN118161669A (zh) * | 2024-05-14 | 2024-06-11 | 上海交通大学医学院附属第九人民医院 | 一种编织的生物牙根及其构建方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103006359A (zh) | 仿生三维立体组织工程支架及其制备方法 | |
Rahmati et al. | Electrospinning for tissue engineering applications | |
US20220162412A1 (en) | Three-dimensional porous hybrid scaffold and manufacture thereof | |
US11946164B2 (en) | Nanofiber structures and methods of use thereof | |
US12029833B2 (en) | Tissue scaffold materials for tissue regeneration and methods of making | |
CN101507835B (zh) | 一种纳米仿生创面覆盖物及其制备方法 | |
Yilgor et al. | Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering | |
US6991652B2 (en) | Tissue engineering composite | |
Chung et al. | Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering | |
CN101829361B (zh) | 一种用于组织修复的纳米仿生材料及其制备方法 | |
JP4619789B2 (ja) | 皮膚およびその他の組織のためのシーラント | |
Elcin et al. | Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge | |
US20190127884A1 (en) | Vascular Constructs | |
US20110263018A1 (en) | Core-shell structured delivery system for growth factors, a preparation method thereof, and use thereof for the differentiation or proliferation of cells | |
JP2004508305A (ja) | 電気処理されたフィブリンをベースとするマトリックスおよび組織 | |
CN102580160A (zh) | 化学键接活性物质的组织工程支架材料及其制备方法 | |
CN104414772A (zh) | 体内可降解吸收的人工医用组织修复膜 | |
MX2011009282A (es) | Duramadre artificial y su metodo de fabricacion. | |
JP2002511284A (ja) | 三次元組織の創造 | |
US20220071920A1 (en) | Membrane | |
CN1733311A (zh) | 一种包裹药物或生长因子的纳米纤维的制备方法 | |
CN109381732A (zh) | 负载生长因子小分子抑制剂的静电纺丝敷料、其制备方法及应用 | |
Wang et al. | Aligned biomimetic scaffolds as a new tendency in tissue engineering | |
CN104689376A (zh) | 一种神经导管及其制备方法 | |
de Lima et al. | Electrospinning of hydrogels for biomedical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NANCHANG SHANYOU BIOTECHNOLOGY CO., LTD. Effective date: 20140331 Owner name: JIANGXI OURUIJIN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG YANG Effective date: 20140331 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 330006 NANCHANG, JIANGXI PROVINCE TO: 330013 NANCHANG, JIANGXI PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140331 Address after: 330013, Nanchang industrial and Technical Development Zone, Jiangxi, 1, Lan Lan Avenue, Taiwan Industrial Park, No. 1 building Applicant after: Jiangxi Ou Rui Jin Biotechnology Co. Ltd. Applicant after: Nanchang Shanyou Biotechnology Co., Ltd. Address before: 330006 Jiangxi Province, Nanchang city East Lake District Road No. 1 Building 3 4 people room unit 602 Applicant before: Wang Yang |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130403 |